Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David John Nutt

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Review of Neurobiology|June 20, 2025
PrefaceDavid John Nutt, Hannah Thurgur
International Review of Neurobiology|March 30, 2024
Reducing the harms of alcohol: nutritional interventions and functional alcohol alternativesDelia Belelli, Antonio Riva, David John Nutt
Journal of Psychoactive Drugs|January 1, 2014
Experienced drug users assess the relative harms and benefits of drugs: a web-based surveyRobin Lester Carhart-Harris, David John Nutt
British Journal of Hospital Medicine (London, England : 2005)|November 24, 2025
Medical Cannabis and Epilepsy: The EvidenceVarinder Kaur, Hannah Deacon, Michael Philip Barnes, et al.
British Journal of Clinical Pharmacology|July 5, 2024
Authors' response to letter 'On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long-COVID'Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
British Journal of Clinical Pharmacology|December 18, 2023
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trialHannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Acta Neuropsychiatrica|May 21, 2019
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line ratOskar Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, et al.
International Review of Neurobiology|March 30, 2024
AUD in perspectiveAndrea de Bejczy, Giovanni Addolorato, Henri-Jean Aubin, et al.
Frontiers in Psychiatry|June 28, 2023
Psychedelic therapy in the treatment of addiction: the past, present and futureRayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Drug and Alcohol Dependence|May 23, 2017
The Standard Joint UnitCristina Casajuana Kögel, María Mercedes Balcells-Olivero, Hugo López-Pelayo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Review of Neurobiology|June 20, 2025
PrefaceDavid John Nutt, Hannah Thurgur
International Review of Neurobiology|March 30, 2024
Reducing the harms of alcohol: nutritional interventions and functional alcohol alternativesDelia Belelli, Antonio Riva, David John Nutt
Journal of Psychoactive Drugs|January 1, 2014
Experienced drug users assess the relative harms and benefits of drugs: a web-based surveyRobin Lester Carhart-Harris, David John Nutt
British Journal of Hospital Medicine (London, England : 2005)|November 24, 2025
Medical Cannabis and Epilepsy: The EvidenceVarinder Kaur, Hannah Deacon, Michael Philip Barnes, et al.
British Journal of Clinical Pharmacology|July 5, 2024
Authors' response to letter 'On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long-COVID'Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
British Journal of Clinical Pharmacology|December 18, 2023
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trialHannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Acta Neuropsychiatrica|May 21, 2019
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line ratOskar Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, et al.
International Review of Neurobiology|March 30, 2024
AUD in perspectiveAndrea de Bejczy, Giovanni Addolorato, Henri-Jean Aubin, et al.
Frontiers in Psychiatry|June 28, 2023
Psychedelic therapy in the treatment of addiction: the past, present and futureRayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Drug and Alcohol Dependence|May 23, 2017
The Standard Joint UnitCristina Casajuana Kögel, María Mercedes Balcells-Olivero, Hugo López-Pelayo, et al.
Pageof 2